Accuracy: 93.07% | Parameters: ~1.4M | Inference: ~47 ms | Size: ~5.6 MB
Overview • Features • Dataset • Architecture • Results • Getting Started
Skin cancer is one of the most prevalent cancers globally, and early detection is critical for improving patient outcomes. EffiDerm is a lightweight Convolutional Neural Network (CNN) engineered for automated skin lesion classification from dermoscopic images.
The model classifies 7 distinct types of skin lesions with 93.07% accuracy while maintaining an exceptionally low computational footprint — only ~1.4M parameters and ~5.6 MB in memory. This makes EffiDerm significantly more efficient than conventional architectures such as ResNet-50 (~25.6M params) or VGG16 (~138M params), enabling real-time inference and deployment in resource-constrained healthcare environments.
| Feature | Detail |
|---|---|
| Lightweight Architecture | ~1.4M parameters — 18× smaller than ResNet-50 |
| High Accuracy | 93.07% classification accuracy across 7 lesion types |
| Fast Inference | ~47 ms per image — suitable for real-time applications |
| Mobile-Ready | ~5.6 MB memory footprint for edge/mobile deployment |
| Class Balancing | SMOTE oversampling to address rare lesion class imbalance |
| Data Augmentation | Rotation, zoom, shift, and flipping for robust generalization |
| Explainability | Grad-CAM heatmap visualizations for interpretable predictions |
This project uses the HAM10000 (Human Against Machine with 10,000 training images) benchmark dataset.
| Property | Details |
|---|---|
| Total Samples | 10,015 dermatoscopic images |
| Classes | 7 skin lesion categories |
| Original Resolution | 600 × 450 px (RGB) |
| Input Resolution | Resized to 64 × 64 × 3 |
| ID | Code | Lesion Type |
|---|---|---|
| 0 | nv |
Melanocytic Nevi |
| 1 | mel |
Melanoma |
| 2 | bkl |
Benign Keratosis-like Lesions |
| 3 | bcc |
Basal Cell Carcinoma |
| 4 | akiec |
Actinic Keratoses |
| 5 | vasc |
Vascular Lesions |
| 6 | df |
Dermatofibroma |
EffiDerm follows a sequential CNN design optimized for a balance between accuracy and computational efficiency.
Input (64×64×3)
│
├─ Conv2D(32) → MaxPool → BatchNorm
├─ Conv2D(64) × 2 → MaxPool → BatchNorm
├─ Conv2D(128) × 2 → MaxPool → BatchNorm
├─ Conv2D(256) × 2 → MaxPool
│
├─ Flatten → Dropout(0.2)
├─ Dense(256) → BatchNorm
├─ Dense(128) → BatchNorm
├─ Dense(64) → BatchNorm
├─ Dense(32) → BatchNorm (L1L2 Regularization)
│
└─ Dense(7, softmax) → Output
- Resized all images to 64 × 64 × 3
- Normalized pixel values to the range [0, 1]
- Applied one-hot encoding to target labels
- Used SMOTE (Synthetic Minority Oversampling Technique) to balance underrepresented classes
| Technique | Configuration |
|---|---|
| Rotation | ±10° |
| Zoom | ±10% |
| Width/Height Shift | ±10% |
| Horizontal/Vertical Flip | Enabled |
| Parameter | Value |
|---|---|
| Optimizer | Adamax (lr = 0.001) |
| Loss Function | Categorical Crossentropy |
| Epochs | 50 |
| Batch Size | 32 |
| LR Scheduler | ReduceLROnPlateau (patience=2, factor=0.5) |
| Train/Test Split | 75% / 25% |
- Accuracy, Precision, Recall, F1-Score
- Confusion Matrix
- Training & Validation Loss/Accuracy Curves
- Grad-CAM Heatmap Visualizations
| Metric | Value |
|---|---|
| Classification Accuracy | 93.07% |
| Inference Time | ~47 ms/image |
| Total Parameters | ~1.4M |
| Model Size | ~5.6 MB |
| Component | Technology |
|---|---|
| Language | Python 3.8 |
| Deep Learning | TensorFlow 2.x, Keras |
| Data Processing | NumPy, Pandas, OpenCV |
| Visualization | Matplotlib, Seaborn |
| Machine Learning | Scikit-learn, Imbalanced-learn |
| IDE | Visual Studio Code |
Python >= 3.8
TensorFlow >= 2.x# Clone the repository
git clone https://github.com/agilkannan/EffiDerm.git
cd EffiDerm
# Install dependencies
pip install tensorflow numpy pandas matplotlib seaborn scikit-learn imbalanced-learn opencv-python- Place the HAM10000 dataset CSV in
./dataset/hmnist_28_28_RGB.csv - Open and run
main.ipynbsequentially - The trained model will be saved as
skin_cancer_model.h5
- Clinical Decision Support — Assist dermatologists with automated lesion classification
- Mobile Screening — Lightweight enough for on-device skin cancer screening apps
- Telemedicine — Enable remote dermatological assessment in underserved areas
- Medical Education — Interactive learning tool for dermatology students and residents
- The model is trained exclusively on dermoscopic images; performance on smartphone-captured images has not been validated
- Classification accuracy is dependent on the quality and diversity of the training dataset
- Clinical deployment requires further validation through prospective studies and regulatory approval
- Enhanced explainability through advanced Grad-CAM and attention-based visualizations
- Model optimization for mobile and edge deployment (TFLite, ONNX)
- Extension to smartphone-captured image datasets for broader applicability
- Integration with cloud-based teledermatology platforms for scalable screening
If you use this work in your research, please cite:
@misc{effiderm2026,
author = {Agil Kannan},
title = {EffiDerm: An Efficient Deep Learning Model for Skin Cancer Prediction},
year = {2026},
publisher = {GitHub},
url = {https://github.com/agilkannan/EffiDerm}
}